AG ANAESTHETICS LIMITED
Opportunity 76/100 (strong), bankability 75/100. Strong seller-intent signal (60/100, director aged 65). Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: share sale to pe / searcher (73/100).
Data confidence
Overall: medium (69/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · accounting standard unknown| Metric | 2025-08-31 | 2024-08-31 |
|---|---|---|
| Average employees | 0 | 0 |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
Recent activity
Corporate timeline (10 events)Click to expand
- 2025-10-28📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2024-11-25📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2024-02-09📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2023-01-11📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2021-12-10📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2020-12-24📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2020-02-05📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2018-08-22🏢Company incorporatedAs AG ANAESTHETICS LIMITED
- 2018-08-22➕GURUNG, Anek Man appointeddirector
- 2018-08-22📄incorporation-companyincorporation · NEWINC
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Sole director: Only one active director — all governance concentrated on one person.
- +Founder age: Director aged approximately 65 — succession pressure is live.
- +No director turnover: Company is 8 years old with no director changes — suggests a very tight-knit founder team never broadened.
Succession & seller-readiness
Multiple signals suggest succession is on the horizon. Candidate for proactive outreach.
- primaryFounder aged 63+: Senior director is approximately 65. Approaching typical UK retirement age — succession thinking likely.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
Red flags
cleanSimilar companies
Active · Healthcare & medical · DN postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| 360 CARE LIMITED→ 06777375 · est 2008 · no financials extracted | — | — | — | — | 17y | — | — |
| ACTIVE8 NORTH LINCS LTD→ 15575628 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
| ACUPUNCTURE AND REHAB CLINIC LIMITED→ 15646126 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
| ADAM GREEN@COMMITTEDCOACHES LTD→ 16654431 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| ADEM MEDICS LTD→ 15800158 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| ADEMEDICS LIMITED→ 15346175 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| ADVANCED CARING (DONCASTER) LIMITED→ 06697289 · est 2008 · no financials extracted | — | — | — | — | 17y | — | — |
| AFFINITY HEALTHCARE PVT LTD→ 17102417 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
| AFRIYE LIMITED→ 09009725 · est 2014 · no financials extracted | — | — | — | — | 11y | — | — |
| AGE UK DONCASTER→ 03802384 · est 1999 · no financials extracted | — | — | — | — | 26y | — | — |
| AGE UK NORTH EAST LINCOLNSHIRE→ 07640867 · est 2011 · no financials extracted | — | — | — | — | 14y | — | — |
| AGE UK NORTH EAST LINCOLNSHIRE TRADING COMPANY LIMITED→ 04107937 · est 2000 · no financials extracted | — | — | — | — | 25y | — | — |
8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 0 resigned)
Click a director name to see their full track record across all companies.